2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Daniel Lin

759 views

August 6, 2020

1 Comment

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

298 views

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta

1.0K views

Nutrition Oncology: A New Frontier

UCLA Health

M. Garcia

726 views

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

121 views

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

437 views

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Yale Cancer Center

C. Balch

339 views

Gastroesophageal Cancer Updates From 2024 Summer Conferences

Debbie's Dream Foundation

S. Klempner

135 views

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

2024 ESMO Annual Meeting Insights Hub

A. Kawazoe

145 views

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Elizabeth Smyth

R. Sundar

238 views

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin

87 views

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

232 views

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab …

2024 ASCO® Annual Meeting Insights Hub

H. Yoon

143 views

Additional Advances in Esophagogastric Cancer Research and Clinical …

Oncology Data Advisor

J. Ajani

135 views

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers -…

2024 ASCO® Annual Meeting Insights Hub

R. Sundar

115 views

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…

Nebraska Oncology Society

R. Safyan

91 views

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

Yale Cancer Center

J. Lacy

110 views

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Integrity CE

K. Bever, R. Voong, J. Hernandez, S. Klempner

147 views

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal…

2024 ASCO® Annual Meeting Insights Hub

A. Shreenivas, S. Chakrabarti

131 views

Targeted Therapy Approaches for Upper GI Cancer

Scripps Health

M. Strickland

106 views

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

ImmunoTherapy Bridge 2023

A. Avallone

217 views

Login

Login

Join VuMedi

2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

Related Content

Recent Updates in Upper Gl Cancers

Year in Review: Upper GI Cancers

Nutrition Oncology: A New Frontier

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Gastroesophageal Cancer Updates From 2024 Summer Conferences

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications…

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab …

Additional Advances in Esophagogastric Cancer Research and Clinical …

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers -…

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal…

Targeted Therapy Approaches for Upper GI Cancer

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…